Search Results - "Mangili, G."

Vaginal delivery in SARS‐CoV‐2‐infected pregnant women in Northern Italy: a retrospective analysis by Ferrazzi, E, Frigerio, L, Savasi, V, Vergani, P, Prefumo, F, Barresi, S, Bianchi, S, Ciriello, E, Facchinetti, F, Gervasi, MT, Iurlaro, E, Kustermann, A, Mangili, G, Mosca, F, Patanè, L, Spazzini, D, Spinillo, A, Trojano, G, Vignali, M, Villa, A, Zuccotti, GV, Parazzini, F, Cetin, I

“…Objective To report mode of delivery and immediate neonatal outcome in women infected with COVID‐19. Design Retrospective study. Setting Twelve hospitals in…”
Get full text

The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study by Mangili, G., Sigismondi, C., Lorusso, D., Cormio, G., Candiani, M., Scarfone, G., Mascilini, F., Gadducci, A., Mosconi, A.M., Scollo, P., Cassani, C., Pignata, S., Ferrandina, G.

“…Surgery followed by platinum-based chemotherapy is the standard of care for MOGCTs, except for stage IA dysgerminoma and stage IA grade 1 immature teratoma…”
Get full text

Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary by Mangili, G, Ottolina, J, Gadducci, A, Giorda, G, Breda, E, Savarese, A, Candiani, M, Frigerio, L, Scarfone, G, Pignata, S, Rossi, R, Marinaccio, M, Lorusso, D

“…Objective: The aim of this study is to evaluate the long-term outcome of granulosa cell tumour (GCT) of the ovary in a large series of patients treated in MITO…”
Get full text

Cerebral superb microvascular imaging in preterm neonates: in vivo evaluation of thalamic, striatal, and extrastriatal angioarchitecture by Barletta, A., Balbi, M., Surace, A., Caroli, A., Radaelli, S., Musto, F., Saruggia, M., Mangili, G., Gerevini, S., Sironi, S.

“…Purpose To explore the potential of superb microvascular imaging (SMI) in visualizing brain microvessels in preterm neonates of different gestational ages…”
Get full text

Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors by Bartoletti, M., Musacchio, L., Giannone, G., Tuninetti, V., Bergamini, A., Scambia, G., Lorusso, D., Valabrega, G., Mangili, G., Puglisi, F., Pignata, S.

“…•PARP inhibitors have opened the era of targeted therapy in ovarian cancer;•Major therapeutic improvements have been limited to the high grade serous…”
Get full text

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial by Lorusso, D., Scambia, G., Pignata, S., Sorio, R., Amadio, G., Lepori, S., Mosconi, A., Pisano, C., Mangili, G., Maltese, G., Sabbatini, R., Artioli, G., Gamucci, T., Di Napoli, M., Capoluongo, E., Ludovini, V., Raspagliesi, F., Ferrandina, G.

“…Current evidence suggest that trabectedin is particularly effective in cells lacking functional homologous recombination repair mechanisms. A prospective phase…”
Get full text

Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO by Vignozzi, L., Malavolta, N., Villa, P., Mangili, G., Migliaccio, S., Lello, S.

Get full text

Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study by Bergamini, A., Cormio, G., Ferrandina, G., Lorusso, D., Giorda, G., Scarfone, G., Bocciolone, L., Raspagliesi, F., Tateo, S., Cassani, C., Savarese, A., Breda, E., De Giorgi, U., Mascilini, F., Candiani, M., Kardhashi, A., Biglia, N., Perrone, A.M., Pignata, S., Mangili, G.

“…About 30% of Adult type granulosa cell tumors of the ovary (AGCTs) are diagnosed in fertile age. In stage I, conservative surgery (fertility-sparing surgery,…”
Get full text

Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia by Mapelli, P., Mangili, G., Picchio, M., Gentile, C., Rabaiotti, E., Giorgione, V., Spinapolice, E. G., Gianolli, L., Messa, C., Candiani, M.

“…Purpose Gestational trophoblastic neoplasia (GTN) is a rare and aggressive tumour that is usually sensitive to chemotherapy. The usefulness of conventional…”
Get full text

Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study by Mangili, G, Ottolina, J, Cormio, G, Loizzi, Vera, De Iaco, P, Pellegrini, D.A, Candiani, M, Giorda, G, Scarfone, G, Cecere, S.C, Frigerio, L, Gadducci, A, Marchetti, C, Ferrandina, G

“…Abstract Objective Evidence-based management of granulosa cell tumors of the ovary (GCT) has been not yet standardized: surgery, including fertility-sparing…”
Get full text

Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin by Bergamini, A, Pisano, C, Di Napoli, M, Arenare, L, Della Pepa, C, Tambaro, R, Facchini, G, Gargiulo, P, Rossetti, S, Mangili, G, Pignata, S, Cecere, S.C

“…Abstract Hypersensitivity reactions (HSR) are frequently reported in patients rechallenged with carboplatin for recurrent ovarian cancer (ROC) and represent a…”
Get full text

EP29.13: The role of uterine artery pulsatility index and a new ultrasound‐guided approach to uterine biopsy in the preoperative evaluation of placental site trophoblastic tumour by Giorgione, V., Cavoretto, P.I., Candiani, M., Mangili, G.

Get full text

A clinical outcome-based prospective study on venous thromboembolism after cancer surgery : The @RISTOS project by AGNELLI, Giancarlo, BOLIS, Giorgio, VALARANI, Bettina, BIANCHINI, Carlo, GUSSONI, Gualberto, CAPUSSOTTI, Lorenzo, SCARPA, Roberto Mario, TONELLI, Francesco, BONIZZONI, Erminio, MOIA, Marco, PARAZZINI, Fabio, ROSSI, Romina, SONAGLIA, Francesco

“…The epidemiology of venous thromboembolism (VTE) after cancer surgery is based on clinical trials on VTE prophylaxis that used venography to screen deep vein…”
Get full text

Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study by Bergamini, A., Ferrandina, G., Candiani, M., Cormio, G., Giorda, G., Lauria, R., Perrone, A.M., Scarfone, G., Breda, E., Savarese, A., Frigerio, L., Gadducci, A., Mascilini, F., Maneschi, F., Cassani, C., Marchetti, C., Cecere, S.C., Biglia, N., De Giorgi, U., Raspagliesi, F., Lorusso, D., Mangili, G.

“…Surgery represents the mainstay of treatment of stage I adult type granulosa cell tumors of the ovary (AGCTs). Because of the rarity and indolent course of the…”
Get full text

Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT) by De Giorgi, U., Richard, S., Badoglio, M., Kanfer, E., Bourrhis, J.H., Nicolas-Virelizier, E., Vettenranta, K., Lioure, B., Martin, S., Dreger, P., Schuler, M.K., Thomson, K., Scarpi, E., Rosti, G., Selle, F., Mangili, G., Lanza, F., Bregni, M.

“…High-dose chemotherapy (HDC) with hematopoietic progenitor cell transplantation is a standard option for relapsed/refractory testicular germ-cell tumor (GCT),…”
Get full text

Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9) by Mangili, G, Scarfone, G, Gadducci, A, Sigismondi, C, Ferrandina, G, Scibilia, G, Viganò, R, Tateo, S, Villa, A, Lorusso, D

“…Abstract Objective. Conservative surgery followed by platinum-based chemotherapy is considered the standard approach for stage I immature ovarian teratoma…”
Get full text

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients by Lorusso, D, Scambia, G, Amadio, G, di Legge, A, Pietragalla, A, De Vincenzo, R, Masciullo, V, Di Stefano, M, Mangili, G, Citterio, G, Mantori, M, Lambiase, A, Bordignon, C

“…Background: The NGR-hTNF (asparagine–glycine–arginine–human tumour necrosis factor) is able to promote antitumour immune responses and to improve the…”
Get full text

Alienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse by Ray-Coquard, I.L., Harter, P., Lorusso, D., Dalban, C., Vergote, I.B., Fujiwara, K., Gladieff, L., Lueck, H.-J., Floquet, A., Lesoin, A.F., Schnelzer, A., Pignata, S., Selle, F., Sehouli, J., Brocard, F., Mangili, G., Pautier, P., De Giorgi, U., Provansal, M., Heudel, P.-E.

Get full text

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer by Piccirillo, M.C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S.C., Di Napoli, M., Salutari, V., Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S., Perrone, F.

“…MITO-8 showed that prolonging platinum-free interval by introducing non-platinum-based chemotherapy (NPBC) does not improve prognosis of patients with…”
Get full text

EP21.14: Fetal cardiac procedures and neonatal outcomes: one centre's experience by Patanè, L., Marcora, S., Ciuffreda, M., Papa, M., Frigerio, L., Galletti, L., Candiano, M., Mangili, G., Strobelt, N.

Get full text